'I've got the emails, let me show you records': AOC pulls receipts, contradicts Zeldin on Bayer meet

Key Concepts

• Glyphosate: The active ingredient in the herbicide Roundup, owned by Bayer/Monsanto, used extensively in U.S. agriculture.
• Non-Hodgkin’s Lymphoma: A type of cancer linked to glyphosate exposure, which is the subject of tens of thousands of lawsuits against Bayer.
• EPA Visitor Logs & FOIA: Official records of agency meetings and internal communications obtained via the Freedom of Information Act.
• Regulatory Capture/Conflict of Interest: The allegation that the EPA is aligning its regulatory stance with Bayer’s legal defense strategy in the Supreme Court.
• State Revolving Funds (SRF): Federal funding mechanisms for drinking and clean water infrastructure.
• FY27 Budget: The proposed federal budget involving significant cuts to water infrastructure funding.

1. Glyphosate Regulation and Legal Controversy

Representative Alexandria Ocasio-Cortez questioned EPA Administrator Lee Zeldin regarding the agency’s relationship with Bayer. The core of the inquiry focused on the potential coordination between the EPA and Bayer to influence Supreme Court litigation.

• The Allegation: Bayer is seeking legal immunity from lawsuits related to glyphosate-induced cancer. The Representative presented evidence suggesting the EPA withdrew support for California’s cancer warning on glyphosate to assist Bayer’s Supreme Court defense.
• Evidence Presented:
  • EPA Visitor Logs (July 7, 2025): Documenting meetings between EPA officials and Bayer leadership.
  • Internal Emails: Obtained via FOIA, these emails from the EPA’s senior adviser for agriculture indicated that Bayer specifically requested to discuss "legal/judicial issues" and "Supreme Court action" during meetings with the EPA.
  • The "Thank You" Note: Internal communications suggested Bayer expressed gratitude to the EPA for updating the glyphosate webpage and removing support for California’s warning, which directly impacts the company's legal standing.
• Administrator Zeldin’s Response: Zeldin denied personal involvement in discussions regarding litigation, characterizing his own meeting with Bayer as a "brief meet and greet." He suggested that internal emails mentioning legal topics were likely the result of staff "brainstorming" potential discussion points rather than active collusion.

2. Water Infrastructure Funding

Representative Mullen shifted the focus to the EPA’s proposed budget and its impact on national water infrastructure.

• The Crisis: The EPA estimates that U.S. drinking water systems require $625 billion and clean water systems require $630 billion in investment.
• Budgetary Conflict: The President’s FY27 budget proposes a 90% cut to the drinking and clean water State Revolving Funds (SRF).
• The Argument: Representative Mullen argued that these cuts shift a "trillion-dollar liability" onto American households, likely resulting in increased monthly water bills.
• Administrator Zeldin’s Defense: Zeldin argued that the current revolving fund model is being undermined by "earmarks" and "grants" that deplete the funds. He stated that the FY27 budget seeks to restore the "revolving" nature of the fund by removing congressionally directed spending, rather than simply cutting support.

Notable Quotes

• Representative Ocasio-Cortez: "We have internal emails from your agency saying that Bayer wanted to thank you and your agency for removing support for California’s warning because their case before the Supreme Court right now hinges on you not warning the American people."
• Administrator Zeldin: "My guidance to dedicated career staffers... is that I don’t want to pre-judge [the assessment due in 2026]."

Synthesis and Conclusion

The hearing highlighted two distinct areas of concern regarding the EPA’s current administration. First, there is a significant tension regarding the agency's independence from corporate influence, specifically concerning Bayer and the legal defense of glyphosate. The evidence presented by Representative Ocasio-Cortez suggests a potential conflict of interest where EPA regulatory actions appear to mirror the legal needs of a multi-billion dollar chemical company. Second, the agency faces a major fiscal challenge regarding water infrastructure; while the administration claims its budget cuts are intended to preserve the structural integrity of the State Revolving Funds, critics view these actions as a dangerous divestment from essential public health infrastructure that will ultimately burden the American taxpayer.